Compounds > clopidogrel

clopidogrel and zithromax

clopidogrel has been researched along with zithromax in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Granero, GE; Mora, MJ; Onnainty, R1
Bykov, K; Gagne, JJ; Glynn, RJ; Mittleman, MA; Schneeweiss, S1

Reviews

1 review(s) available for clopidogrel and zithromax

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for clopidogrel and zithromax

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Comparative Oral Drug Classification Systems: Acetazolamide, Azithromycin, Clopidogrel, and Efavirenz Case Studies.
    Molecular pharmaceutics, 2018, 08-06, Volume: 15, Issue:8

    Topics: Acetazolamide; Administration, Oral; Alkynes; Animals; Azithromycin; Benzoxazines; Biological Assay; Biological Availability; Biopharmaceutics; Clopidogrel; Cyclopropanes; Drug Evaluation, Preclinical; Feasibility Studies; Intestinal Absorption; Intestinal Mucosa; Perfusion; Permeability; Rats; Solubility

2018
The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation.
    Epidemiology (Cambridge, Mass.), 2019, Volume: 30, Issue:2

    Topics: Administrative Claims, Healthcare; Azithromycin; Clarithromycin; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Electronic Health Records; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Implementation Science; Models, Statistical; Rhabdomyolysis; Risk Factors; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome

2019